Form 4 for TARS Tarsus Pharmaceuticals, Inc.

Accepted 2021-11-16 00:00:00 ET · period of report 2021-11-11 · accession 0001209191-21-064905 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
MI	2021-11-16	2021-11-11	TARS	LINK WILLIAM J PHD	Dir	J - Other	$0.00	-245.7K	862.3K	-22%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2021-11-11	J	A	4,348	$0.00	4,348	I By Flying L Partners XI, LLC	—	—	(F4) The shares are held directly held by Flying L Partners XI, LLC. The Reporting Person is the manager of Flying L Partners XI, LLC and may be deemed to have sole voting and investment power over the shares. The Reporting Person disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein.
2	Common	Common Stock	2021-11-11	J	D	250,000	$0.00	862,301	I By Flying L Investments XI, LLC	—	—	(F2) The shares are held directly held by Flying L Investments XI, LLC. The Reporting Person is the manager of Flying L Investments XI, LLC and may be deemed to have sole voting and investment power over the shares. The Reporting Person disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein.